ETFs

Cardinal Health, Inc. (NYSE:CAH) Given Average Rating o...

Cardinal Health, Inc. (NYSE:CAH – Get Free Report) has been given a consensus re...

Arhaus, Inc. (NASDAQ:ARHS) Receives Average Recommendat...

Arhaus, Inc. (NASDAQ:ARHS – Get Free Report) has been given a consensus recommen...

Lincoln Electric Holdings, Inc. (NASDAQ:LECO) Receives ...

Shares of Lincoln Electric Holdings, Inc. (NASDAQ:LECO – Get Free Report) have b...

Head to Head Review: Legrand (OTCMKTS:LGRDY) & General ...

Legrand (OTCMKTS:LGRDY – Get Free Report) and General Electric (NYSE:GE – Get Fr...

Financial Review: Simon Worldwide (OTCMKTS:SWWI) & Amer...

Simon Worldwide (OTCMKTS:SWWI – Get Free Report) and Amer Sports (NYSE:AS – Get ...

Contrasting BV Financial (BVFL) and Its Rivals

Institutional & Insider Ownership 42.7% of BV Financial shares are held by insti...

Ormat Technologies, Inc. (NYSE:ORA) Receives Consensus ...

Shares of Ormat Technologies, Inc. (NYSE:ORA – Get Free Report) have been given ...

Willis Towers Watson Public Limited (NASDAQ:WTW) Receiv...

Willis Towers Watson Public Limited (NASDAQ:WTW – Get Free Report) has been assi...

Financial Analysis: Tactile Systems Technology (NASDAQ:...

Tactile Systems Technology (NASDAQ:TCMD – Get Free Report) and Insulet (NASDAQ:P...

Lazard, Inc. (NYSE:LAZ) Receives Average Rating of “Hol...

Shares of Lazard, Inc. (NYSE:LAZ – Get Free Report) have been given a consensus ...

Rexford Industrial Realty (NYSE:REXR) versus Global Sel...

Rexford Industrial Realty (NYSE:REXR – Get Free Report) and Global Self Storage ...

Financial Survey: Lucky Strike Entertainment (LUCK) and...

Lucky Strike Entertainment (NYSE:LUCK – Get Free Report) is one of 42 public com...

AppLovin’s (APP) “Hold” Rating Reiterated at Needham & ...

Needham & Company LLC reaffirmed their hold rating on shares of AppLovin (NASDAQ...

Bridgeline Digital (NASDAQ:BLIN) Upgraded at Westpark C...

Bridgeline Digital (NASDAQ:BLIN – Get Free Report) was upgraded by investment an...

Arrowhead Pharmaceuticals’ (ARWR) “Buy” Rating Reaffirm...

Arrowhead Pharmaceuticals (NASDAQ:ARWR – Get Free Report)‘s stock had its “buy” ...

AppLovin (NASDAQ:APP) Price Target Raised to $575.00

AppLovin (NASDAQ:APP – Free Report) had its price objective lifted by Piper Sand...

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.